Dr. Starr is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4500 San Pablo Rd S
Jacksonville, FL 32224Phone+1 904-953-2000
Education & Training
- Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 2011 - 2014
- Mayo Clinic College of Medicine and Science (Jacksonville)Residency, Internal Medicine, 2008 - 2011
- Lake Erie College of Osteopathic Medicine Bradenton CampusClass of 2008
Certifications & Licensure
- FL State License 2010 - 2026
- TN State License 2020 - 2023
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Regorafenib, With Cetuximab or Panitumumab, for the Treatment of Unresectable, Locally Advanced, or Metastatic Colorectal Cancer Start of enrollment: 2020 Mar 03
Publications & Presentations
PubMed
- 45 citations5-FU induced cardiotoxicity: case series and review of the literatureCai Yuan, Hiral D. Parekh, Carmen J. Allegra, Thomas J. George, Jason S. Starr
Cardio-Oncology. 2019-09-06 - 4 citationsA Systematic Review of Nutritional Lab Correlates with Chemotherapy Induced Peripheral Neuropathy.Cindy Tofthagen, Mary Tanay, Adam Perlman, Jason Starr, Pooja Advani
Journal of Clinical Medicine. 2022-01-12 - 107 citationsImmunotherapy for Colorectal Cancer: A Review of Current and Novel Therapeutic ApproachesAaron J Franke, William Paul Skelton, Jason S. Starr, Hiral D. Parekh, James J. Lee
Journal of the National Cancer Institute. 2019-11-01
Press Mentions
- Sharing Mayo Clinic: Georgia Man with Neuroendocrine Cancer Gains Quality of Life Thanks to New Nuclear Med TherapyApril 17th, 2022
- Georgia Man with Neuroendocrine Cancer Gains Quality of Life Thanks to New Nuclear Med TherapyApril 14th, 2022
- New York's Cannabis Board Holds First Meeting, Amends Medical ProgramOctober 5th, 2021
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: